Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

Mibampator

Index Mibampator

Mibampator (developmental code name LY-451395) is a positive allosteric modulator (PAM) of the AMPA receptor (AMPAR), an ionotropic glutamate receptor, which was under development by Eli Lilly for the treatment of agitation/aggression in Alzheimer's disease but was never marketed. [1]

22 relations: Aggression, Agitation (dementia), Allosteric modulator, Alzheimer's disease, AMPA receptor, AMPA receptor positive allosteric modulator, Clinical trial, Cognition, Congener (chemistry), Convulsion, CX-516, Eli Lilly, Farampator, Ionotropic glutamate receptor, LY-404187, LY-503430, Memory, Motor coordination, Motor disorder, Neurotoxicity, PF-04958242, Toxicity.

Aggression

Aggression is overt, often harmful, social interaction with the intention of inflicting damage or other unpleasantness upon another individual.

New!!: Mibampator and Aggression · See more »

Agitation (dementia)

Agitation often accompanies dementia and often precedes the diagnosis of common age-related disorders of cognition such as Alzheimer's disease (AD).

New!!: Mibampator and Agitation (dementia) · See more »

Allosteric modulator

In biochemistry and pharmacology, an allosteric modulator (allo- from the Greek meaning "other") is a substance which indirectly influences (modulates) the effects of a primary ligand that directly activates or deactivates the function of a target protein.

New!!: Mibampator and Allosteric modulator · See more »

Alzheimer's disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

New!!: Mibampator and Alzheimer's disease · See more »

AMPA receptor

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (also known as AMPA receptor, AMPAR, or quisqualate receptor) is an ionotropic transmembrane receptor for glutamate that mediates fast synaptic transmission in the central nervous system (CNS).

New!!: Mibampator and AMPA receptor · See more »

AMPA receptor positive allosteric modulator

AMPA receptor positive allosteric modulators are positive allosteric modulators (PAMs) of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPR), a type of ionotropic glutamate receptor which mediates most fast synaptic neurotransmission in the central nervous system.

New!!: Mibampator and AMPA receptor positive allosteric modulator · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

New!!: Mibampator and Clinical trial · See more »

Cognition

Cognition is "the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses".

New!!: Mibampator and Cognition · See more »

Congener (chemistry)

In chemistry, congeners are related chemical substances "related to each other by origin, structure, or function".

New!!: Mibampator and Congener (chemistry) · See more »

Convulsion

A convulsion is a medical condition where body muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body.

New!!: Mibampator and Convulsion · See more »

CX-516

CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier.

New!!: Mibampator and CX-516 · See more »

Eli Lilly

Eli Lilly (July 8, 1838 – June 6, 1898) was an American soldier, pharmacist, chemist, and businessman who founded the Eli Lilly and Company pharmaceutical corporation.

New!!: Mibampator and Eli Lilly · See more »

Farampator

Farampator (developmental code names CX-691, ORG-24448, SCH-900460) is an ampakine drug.

New!!: Mibampator and Farampator · See more »

Ionotropic glutamate receptor

Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that are activated by the neurotransmitter glutamate.

New!!: Mibampator and Ionotropic glutamate receptor · See more »

LY-404187

LY-404187 is an AMPA receptor positive allosteric modulator which was developed by Eli Lilly and Company.

New!!: Mibampator and LY-404187 · See more »

LY-503430

LY-503430 is an AMPA receptor positive allosteric modulator developed by Eli Lilly.

New!!: Mibampator and LY-503430 · See more »

Memory

Memory is the faculty of the mind by which information is encoded, stored, and retrieved.

New!!: Mibampator and Memory · See more »

Motor coordination

Motor coordination is the combination of body movements created with the kinematic (such as spatial direction) and kinetic (force) parameters that result in intended actions.

New!!: Mibampator and Motor coordination · See more »

Motor disorder

Motor disorders are disorders of the nervous system that cause abnormal and involuntary movements.

New!!: Mibampator and Motor disorder · See more »

Neurotoxicity

Neurotoxicity is a form of toxicity in which a biological, chemical, or physical agent produces an adverse effect on the structure or function of the central and/or peripheral nervous system.

New!!: Mibampator and Neurotoxicity · See more »

PF-04958242

PF-04958242 is a positive allosteric modulator (PAM) of the AMPA receptor (AMPAR), an ionotropic glutamate receptor, which is under development by Pfizer for the treatment of cognitive symptoms in schizophrenia.

New!!: Mibampator and PF-04958242 · See more »

Toxicity

Toxicity is the degree to which a chemical substance or a particular mixture of substances can damage an organism.

New!!: Mibampator and Toxicity · See more »

Redirects here:

LY 451,395, LY 451395, LY-451,395, LY-451395, LY451,395, LY451395.

References

[1] https://en.wikipedia.org/wiki/Mibampator

OutgoingIncoming
Hey! We are on Facebook now! »